Clinical Trial Detail

NCT ID NCT01262027
Title TKI258 for Metastatic Inflammatory Breast Cancer Patients
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center|Novartis
Indications

Her2-receptor negative breast cancer

breast cancer

Therapies

Dovitinib

Age Groups: adult

Additional content available in CKB BOOST